FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jean-Jacques Lefrère

Research Profile

Procedures

Living Beings

Disorders

Chemicals & Drugs

Geographic Areas

France

Phenomena

HIV Seropositivity

Concepts & Ideas

Co-author Network

Publications

TOP 3
Jean-Jacques Lefrère; Frédéric Rouillon
The great neurosis of Dr. Joseph Gerard.
Jean-Jacques Lefrère
Transfusion medicine history illustrated. Giving blood with music.
H Dahourou; M Diallo; K Kiénou; E Murphy; Y Nébié; M Sanou; Jean-Baptiste Tapko; L Barro; Jean-Jacques Lefrère
[Implementation of hemovigilance in Sub-Saharan Africa].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jean-Jacques Lefrère (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jean-Jacques Lefrère; Frédéric Rouillon
The great neurosis of Dr. Joseph Gerard.
Frontiers of neurology and neuroscience 2013;31():52-9.
2012: Jean-Jacques Lefrère
Transfusion medicine history illustrated. Giving blood with music.
Transfusion 2012;52(4):693.
2012: H Dahourou; M Diallo; K Kiénou; E Murphy; Y Nébié; M Sanou; Jean-Baptiste Tapko; L Barro; Jean-Jacques Lefrère
[Implementation of hemovigilance in Sub-Saharan Africa].
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2012;19(1):39-45.
2011: Jean-Jacques Lefrère
Transfusion medicine history illustrated. Arming for war: the donor's arm.
Transfusion 2011;51(10):2064-5.
2011: Jean-Jacques Lefrère
[Expected limits (and possible consequences) of pathogen inactivation technology].
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2011;18(4):468-71.
2011: G Andreu; J-P Cazenave; Olivier GARRAUD; Jean-Jacques Lefrère
[Pathogen inactivation technologies: a complex but necessary debate].
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2011;18(4):443.
2011: Jean-Jacques Lefrère
Transfusion medicine history illustrated: A historic picture: the first transfusion of citrated blood.
Transfusion 2011;51(6):1140-1.
2011: Syria Laperche; Françoise Bouchardeau; Elisabeth André-Garnier; Vincent Thibault; Anne-Marie Roque-Afonso; Pascale Trimoulet; Ronald Colimon; Gilles Duverlie; Hélène Leguillou-Guillemette; Françoise Lunel; Magali Bouvier-Alias; Jean-Michel Pawlotsky; Cécile Henquell; Evelyne Schvoerer; Françoise Stoll-Keller; Marie-Laure Chaix; Michel Branger; Catherine Gaudy-Graffin; Arielle R Rosenberg; Bruno POZZETTO; Sophie Vallet; Yazid Baazia; Jacques Izopet; Jean-Jacques Lefrère
Interpretation of real-time PCR results for hepatitis C virus RNA when viral load is below quantification limits.
Journal of clinical microbiology 2011;49(3):1113-5.
2011: Jean-Jacques Lefrère; Honorine Dahourouh; Alexis E Dokekias; Maxime D Kouao; Amadou Diarra; Saliou Diop; Jean-Baptiste Tapko; Edward L Murphy; Syria Laperche; Josiane Pillonel
Estimate of the residual risk of transfusion-transmitted human immunodeficiency virus infection in sub-Saharan Africa: a multinational collaborative study.
Transfusion 2011;51(3):486-92.
2011: Jean-Jacques Lefrère; Patrick Berche
Les bébés du thalidomide.
Presse médicale (Paris, France : 1983) 2011;40(3):301-8.
2011: Claude Tagny Tayou; Dora Mbanya; Lionel Leballais; Edward Murphy; Jean-Jacques Lefrère; Syria Laperche
Reduction of the risk of transfusion-transmitted human immunodeficiency virus (HIV) infection by using an HIV antigen/antibody combination assay in blood donation screening in Cameroon.
Transfusion 2011;51(1):184-90.
2010: P Jaulin; Jean-Jacques Lefrère
[First French transfusions (1667-1668)].
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2010;17(4):205-17.
2010: Annabelle Servant-Delmas; Jean-Jacques Lefrère; Frédéric Morinet; Sylvie Pillet
Advances in human B19 erythrovirus biology.
Journal of virology 2010;84(19):9658-65.
2010: Jean-Jacques Lefrère; Patrick Berche
[Laennec invents the stethoscope].
Presse médicale (Paris, France : 1983) 2010;39(7-8):823-32.
2010: Jean-Jacques Lefrère; Patrick Berche
[Andreas Vesalius, pionnier of the human anatomy].
Presse médicale (Paris, France : 1983) 2010;39(6):713-21.
2010: Jean-Jacques Lefrère; P Berche
[Karl Landsteiner discovers the blood groups].
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2010;17(1):1-8.
2009: A Servant-Delmas; M Mercier; Syria Laperche; Jean-Jacques Lefrère
[Genetic diversity of human erythroviruses. Consequences on infectious safety of plasma derivatives].
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2009;16(5-6):482-8.
2009: Jean-Jacques Lefrère; C Shiboski; A Fontanet; E L Murphy
[Teaching transfusion medicine research in the francophone world].
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2009;16(5-6):427-30.
2009: Annabelle Servant-Delmas; Syria Laperche; Mélanie Mercier; Marie-Hélène Elghouzzi; François Lionnet; Katia Stankovic; Robert Girot; Jean-Jacques Lefrère
Human parvovirus 4 in recipients of cellular products and in blood donors: epidemiologic similarity with B19 parvovirus.
Transfusion 2009;49(8):1771-3.
2009: Syria Laperche; Geneviève Boukatou; Léonard Kouegnigan; Yacouba Nébié; Mohamed Ould Boulahi; Claude Tagny Tayou; Rakia Yahaya; Jean-Baptiste Tapko; Edward Murphy; Jean-Jacques Lefrère
Transfusion safety on the African continent: an international quality control of virus testing in blood banks.
Transfusion 2009;49(8):1600-8.
2009: Jean-Jacques Lefrère; N Coudurier
[Biobanks and blood transfusion in France: a tool for public health].
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2009;16(2):148-51.
2009: Jean-Jacques Lefrère; Patricia Hewitt
From mad cows to sensible blood transfusion: the risk of prion transmission by labile blood components in the United Kingdom and in France.
Transfusion 2009;49(4):797-812.
2009: A Servant-Delmas; Syria Laperche; M Mercier; Jean-Jacques Lefrère
[Genetic diversity of human Erythroviruses].
Pathologie-biologie 2009;57(2):167-74.
2008: Claude Tagny Tayou; Dora Mbanya; Jean-Baptiste Tapko; Jean-Jacques Lefrère
Blood safety in Sub-Saharan Africa: a multi-factorial problem.
Transfusion 2008;48(6):1256-61.
2008: Bruno Danic; Jean-Jacques Lefrère
Transfusion and blood donation on the screen.
Transfusion 2008;48(5):1027-31.
2008: Jean-Jacques Lefrère; Syria Laperche; Robert Girot
Repository of blood samples from recipients of red blood cell transfusions in France.
Transfusion 2008;48(1):195; author reply 195-6.
2007: Syria Laperche; Françoise Bouchardeau; Vincent Thibault; Bruno POZZETTO; Sophie Vallet; Arielle R Rosenberg; Anne-Marie Roque-Afonso; Michelle Gassin; Françoise Stoll-Keller; Pascale Trimoulet; Elyanne Gault; Bruno Chanzy; Bernard Mercier; Michel Branger; Jean-Michel Pawlotsky; Cécile Henquell; Françoise Lunel; Catherine Gaudy-Graffin; Sophie Alain; Marie-Laure Chaix; Gilles Duverlie; Jacques Izopet; Jean-Jacques Lefrère
Multicenter trials need to use the same assay for hepatitis C virus viral load determination.
Journal of clinical microbiology 2007;45(11):3788-90.
2007: Jean-Jacques Lefrère; Nicolas Guillaume; Syria Laperche
Should cellular therapy products be tested for human herpesvirus 8?
Transfusion 2007;47(8):1550.
2007: Jean-Jacques Lefrère
[The risk of prion contamination through the transfusion of cellular products].
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2007;14(1):25-34.
2007: Françoise Bouchardeau; Jean-François Cantaloube; Stéphane Chevaliez; Christine Portal; Annie Razer; Jean-Jacques Lefrère; Jean-Michel Pawlotsky; Philippe de Micco; Syria Laperche
Improvement of hepatitis C virus (HCV) genotype determination with the new version of the INNO-LiPA HCV assay.
Journal of clinical microbiology 2007;45(4):1140-5.
2006: Syria Laperche; Vincent Thibault; Françoise Bouchardeau; Sophie Alain; Sandrine Castelain; Michelle Gassin; Marie Gueudin; Philippe Halfon; Sylvie Larrat; Françoise Lunel; Michèle Martinot-Peignoux; Bernard Mercier; Jean-Michel Pawlotsky; Bruno POZZETTO; Anne-Marie Roque-Afonso; Françoise Roudot-Thoraval; Karine Sauné; Jean-Jacques Lefrère
Expertise of laboratories in viral load quantification, genotyping, and precore mutant determination for hepatitis B virus in a multicenter study.
Journal of clinical microbiology 2006;44(10):3600-7.
2006: H Petit; Syria Laperche; Jean-Jacques Lefrère
[Application of pre- and post-transfusion virological controls prior to the suppression of their recommendation].
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2006;13(4):246-52.
2006: Jean-Jacques Lefrère; Michèle Maniez-Montreuil; Pascal Morel; Christine Defer; Syria Laperche
[Safety of blood products and B19 parvovirus].
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2006;13(4):235-41.
2006: Valérie Gras-Champel; Annelise Voyer; Nicolas Guillaume; Céline Lematte; Bertrand Roussel; Charlotte Machu-Prestaux; Michel Andréjak; Jean-Jacques Lefrère
Quality evaluation of the management of oral anticoagulation therapy (OAT): the awareness of treating physicians and the education of patients needs to be improved.
American journal of therapeutics 2006;13(3):223-8.
2006: Syria Laperche; Karine Saune; Paul Dény; Gilles Duverlie; Sophie Alain; Marie-Laure Chaix; Catherine Gaudy; Françoise Lunel; Jean-Michel Pawlotsky; Christopher Payan; Bruno POZZETTO; Catherine Tamalet; Vincent Thibault; Sophie Vallet; Françoise Bouchardeau; Jacques Izopet; Jean-Jacques Lefrère
Unique NS5b hepatitis C virus gene sequence consensus database is essential for standardization of genotype determinations in multicenter epidemiological studies.
Journal of clinical microbiology 2006;44(2):614-6.
2005: Jean-Jacques Lefrère; Annabelle Servant-Delmas; Daniel Candotti; Martine Mariotti; Isabelle Thomas; Yves Brossard; François Lefrère; Robert Girot; Jean-Pierre Allain; Syria Laperche
Persistent B19 infection in immunocompetent individuals: implications for transfusion safety.
Blood 2005;106(8):2890-5.
2005: Nicolas Guillaume; Céline Alleaume; Délicia Munfus; Jean-Claude Capiod; Gilles Touati; Brigitte Pautard; Bernard Desablens; Jean-Jacques Lefrère; Fabrice Gouilleux; Kaiss Lassoued; Valérie Gouilleux-Gruart
ZAP-70 tyrosine kinase is constitutively expressed and phosphorylated in B-lineage acute lymphoblastic leukemia cells.
Haematologica 2005;90(7):899-905.
2005: Jean-Jacques Lefrère
[The BOTIA project ("Blood and Organ Transmissible Infectious Agents"): a European collection of blood samples and an observatory of agents transmitted by blood transfusion or organ transplantation].
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2005;12(2):93-4.
2005: jean-luc wautier; F Vileyn; Jean-Jacques Lefrère
[Electronic learning: interactive learning in medicine or Socrates in electronic guise].
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2005;12(2):150-2.
2005: Valérie Gras-Champel; Annelise Voyer; Céline Lematte; Pauline Pakula; Bertrand Roussel; Jean-Jacques Lefrère; Michel Andréjak
[Assessment of the quality of oral anticoagulation management in patients admitted to Amiens University Hospital].
Thérapie 2005;60(2):149-57.
2005: jean-luc wautier; J-J Cabaud; J-P Cazenave; P Fialon; MF Fruchart; M Joussemet; V Leblond; J-Y Muller; Philippe Rouger; D Vignon; C Waller; Jean-Jacques Lefrère; B Worms; F Vileyn
[French training program for medical students in transfusion medicine. Transfusion Medicine Teachers' College].
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2005;12(1):59-69.
2005: Syria Laperche; Françoise Lunel; Jacques Izopet; Sophie Alain; Paul Dény; Gilles Duverlie; Catherine Gaudy; Jean-Michel Pawlotsky; Jean-Christophe Plantier; Bruno POZZETTO; Vincent Thibault; François Tosetti; Jean-Jacques Lefrère
Comparison of hepatitis C virus NS5b and 5' noncoding gene sequencing methods in a multicenter study.
Journal of clinical microbiology 2005;43(2):733-9.
2004: Jean-Jacques Lefrère
[Discussions about Europe].
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2004;11(5-6):257-9.
2004: Jean-Jacques Lefrère; Martine Mariotti; Syria Laperche; Yves Brossard; Robert Girot; François Lefrère
Prevalence of Borna disease virus RNA in populations at high or low risk for blood-borne infections.
Transfusion 2004;44(9):1396.
2004: Jean-Jacques Lefrère; Françoise Roudot-Thoraval; Françoise Lunel; Sophie Alain; Marie-Laure Chaix; Elisabeth Dussaix; Michelle Gassin; Jacques Izopet; Jean-Michel Pawlotsky; Christopher Payan; Françoise Stoll-Keller; Vincent Thibault; Mary-Anne Trabaud; Dominique Bettinger; Marc Bogard; Michel Branger; Claudine Buffet-Janvresse; Anne Charrois; Christine Defer; Catherine Laffont; Joëlle Lerable; Thierry Levayer; Michèle Martinot-Peignoux; Bernard Mercier; Arielle R Rosenberg
Expertise of French laboratories in detection, genotyping, and quantification of hepatitis C virus RNA in serum.
Journal of clinical microbiology 2004;42(5):2027-30.
2004: Syria Laperche; Françoise Bouchardeau; Michèle Maniez; M Béolet; Marie-Hélène Elghouzzi; Jean-Jacques Lefrère
Nucleic acid testing in blood donations reactive to hepatitis C virus antibody, but with an extremely low viral load.
Vox sanguinis 2004;86(3):198.
2004: Jean-Jacques Lefrère; Laurence Morand-Joubert
Non-progression of HIV infection 20 years after diagnosis.
Transfusion 2004;44(4):623-4.
2004: Jean-Jacques Lefrère; Robert Girot; François Lefrère; Nicolas Guillaume; Joëlle Lerable; Nadine Le Marrec; Françoise Bouchardeau; Syria Laperche
Complete or partial seroreversion in immunocompetent individuals after self-limited HCV infection: consequences for transfusion.
Transfusion 2004;44(3):343-8.
2004: Jean-Jacques Lefrère
[In memory of Jean-Pierre Soulier, the writer].
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2004;11(1):71-3.
2003: Syria Laperche; Pascal Morel; Marie Deschaseaux; Françoise Bouchardeau; Gulie Alimardani; Nicolas Guillaume; Philippe Rouger; Jean-Jacques Lefrère
HIV antibody screening remains indispensable for ensuring viral safety of blood components despite NAT implementation.
Transfusion 2003;43(10):1428-32.
2003: Syria Laperche; Nadine Le Marrec; Nicole Simon; Françoise Bouchardeau; Christine Defer; Michèle Maniez-Montreuil; Thierry Levayer; Jean-Pierre Zappitelli; Jean-Jacques Lefrère
A new HCV core antigen assay based on disassociation of immune complexes: an alternative to molecular biology in the diagnosis of early HCV infection.
Transfusion 2003;43(7):958-62.
2002: Syria Laperche; Philippe Rouger; Winston Smilovici; Patrick Hervé; Jean-Jacques Lefrère
Alternatives to nucleic acid testing in the blood transfusion service.
Lancet 2002;360(9344):1519.
2001: Dominique Challine; Françoise Roudot-Thoraval; T Sarah; L Laperche; B Boisson; S Mauberquez; F Dubernet; Pierrette Rigot; François Lefrère; Bernard Mercier; Yves Brossard; F Rouet; Robert Girot; Pascale Loiseau; D Girard; Jacky Claquin; Bernard Loty; Joëlle Lerable; Martine Mariotti; Jean-Michel Pawlotsky; Jean-Jacques Lefrère
Seroprevalence of human herpes virus 8 antibody in populations at high or low risk of transfusion, graft, or sexual transmission of viruses.
Transfusion 2001;41(9):1120-5.
2000: Jean-Jacques Lefrère; Alfred Sender; Bernard Mercier; Martine Mariotti; F Pernot; J C Soulié; A Malvoisin; M Berry; A Gabai; F Lattes; J C Galiay; C Pawlak; V de Lachaux; V Chauveau; G Hreiche; M Larsen; C Férec; F Parnet-Mathieu; Françoise Roudot-Thoraval; Yves Brossard
High rate of GB virus type C/HGV transmission from mother to infant: possible implications for the prevalence of infection in blood donors.
Transfusion 2000;40(5):602-7.
2000: Jean-Jacques Lefrère; Joëlle Lerable; Martine Mariotti; Marc Bogard; Vincent Thibault; L Frangeul; Pascale Loiseau; Françoise Bouchardeau; Syria Laperche; Jean-Michel Pawlotsky; Jean-François Cantaloube; Philippe Biagini; Xavier de Lamballerie; Jacques Izopet; Christine Defer; I Lepot; J D Poveda; Elisabeth Dussaix; Victoria Gerolami; Philippe Halfon; Claudine Buffet-Janvresse; C Férec; Bernard Mercier; P Marcellin; Michèle Martinot-Peignoux; M Gassain
Lessons from a multicentre study of the detectability of viral genomes based on a two-round quality control of GB virus C (GBV-C)/hepatitis G virus (HGV) polymerase chain reaction assay.
Journal of virological methods 2000;85(1-2):117-24.
2000: Jean-Jacques Lefrère; Françoise Roudot-Thoraval; François Lefrère; Alain Kanfer; Martine Mariotti; Joëlle Lerable; M Thauvin; G Lefèvre; Philippe Rouger; Robert Girot
Natural history of the TT virus infection through follow-up of TTV DNA-positive multiple-transfused patients.
Blood 2000;95(1):347-51.
1999: Jean-Jacques Lefrère; C Férec; Françoise Roudot-Thoraval; Pascale Loiseau; Jean-François Cantaloube; Philippe Biagini; Martine Mariotti; G LeGac; Bernard Mercier
GBV-C/hepatitis G virus (HGV) RNA load in immunodeficient individuals and in immunocompetent individuals.
Journal of medical virology 1999;59(1):32-7.
1999: Jean-Jacques Lefrère; Martine Mariotti; Laurence Morand-Joubert; M Thauvin; Françoise Roudot-Thoraval
Plasma human immunodeficiency virus RNA below 40 Copies/mL is rare in untreated persons even in the first years of infection.
The Journal of infectious diseases 1999;180(2):526-9.
1999: Jean-Jacques Lefrère; Jean-François Cantaloube; Christine Defer; Bernard Mercier; Pascale Loiseau; D Vignon; Jean-Michel Pawlotsky; Philippe Biagini; Joëlle Lerable; Philippe Rouger; Françoise Roudot-Thoraval; C Férec
Screening for HBV, HCV and HIV genomes in blood donations: shortcomings of pooling revealed by a multicentre study simulating real-time testing.
Journal of virological methods 1999;80(1):33-44.
1999: Jean-Jacques Lefrère; Françoise Roudot-Thoraval; Laurence Morand-Joubert; Jean-Claude Petit; Joëlle Lerable; M Thauvin; Martine Mariotti
Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons.
The Journal of infectious diseases 1999;179(4):783-9.
1999: Jean-Jacques Lefrère; Françoise Roudot-Thoraval; Laurence Morand-Joubert; Yves Brossard; F Parnet-Mathieu; Martine Mariotti; F Agis; G Rouet; Joëlle Lerable; G Lefèvre; Robert Girot; Pascale Loiseau
Prevalence of GB virus type C/hepatitis G virus RNA and of anti-E2 in individuals at high or low risk for blood-borne or sexually transmitted viruses: evidence of sexual and parenteral transmission.
Transfusion 1999;39(1):83-94.
1998: Jean-Jacques Lefrère; J Coste; Christine Defer; Bernard Mercier; C Férec; Pascale Loiseau; E Portelette; Martine Mariotti; Joëlle Lerable; Philippe Rouger; Jean-Michel Pawlotsky
Screening blood donations for viral genomes: multicenter study of real-time simulation using pooled samples on the model of hepatitis C virus RNA detection.
Transfusion 1998;38(10):915-23.
1998: Jean-Jacques Lefrère; Françoise Roudot-Thoraval; Martine Mariotti; M Thauvin; Joëlle Lerable; J Salpétrier; Laurence Morand-Joubert
The risk of disease progression is determined during the first year of human immunodeficiency virus type 1 infection.
The Journal of infectious diseases 1998;177(6):1541-8.
1998: Jean-Jacques Lefrère
[Molecular biology and transfusional viral safety].
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 1998;5(1):22-38.
1997: Jean-Jacques Lefrère; Pascale Loiseau; J Maury; J Lasserre; Martine Mariotti; N Ravera; Joëlle Lerable; G Lefèvre; Laurence Morand-Joubert; Robert Girot
Natural history of GBV-C/hepatitis G virus infection through the follow-up of GBV-C/hepatitis G virus-infected blood donors and recipients studied by RNA polymerase chain reaction and anti-E2 serology.
Blood 1997;90(9):3776-80.
1997: Jean-Jacques Lefrère; Laurence Morand-Joubert; Martine Mariotti; H Bludau; Béatrice Burghoffer; Jean-Claude Petit; Françoise Roudot-Thoraval
Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection.
Blood 1997;90(3):1133-40.
1997: Jean-Jacques Lefrère; Martine Mariotti; Robert Girot; P Loiseau; P Hervé
Transfusional risk of HHV-8 infection.
Lancet 1997;350(9072):217.
1997: Pascale Loiseau; Martine Mariotti; C Corbi; N Ravera; Robert Girot; M Thauvin; E Portelette; X Mariette; Françoise Roudot-Thoraval; Marc Benbunan; Jean-Jacques Lefrère
Prevalence of hepatitis G virus RNA in French blood donors and recipients.
Transfusion 1997;37(6):645-50.
1997: Jean-Jacques Lefrère; F Sellami; Patrick Larderie; C Lemaillot; Françoise Roudot-Thoraval; Jacky Claquin
Six years' experience testing organ donors for viral markers in France.
Transfusion 1997;37(5):565-6.
1997: Jean-Jacques Lefrère; S Guiramand; François Lefrère; Martine Mariotti; P Aumont; Joëlle Lerable; Jean-Claude Petit; Robert Girot; Laurence Morand-Joubert
Full or partial seroreversion in patients infected by hepatitis C virus.
The Journal of infectious diseases 1997;175(2):316-22.
1997: Jean-Jacques Lefrère; N Ravera; C Corbi; Martine Mariotti; Pascale Loiseau
Infection with hepatitis G virus in immunoglobulin recipients.
Lancet 1997;349(9046):206.
1997: Laurence Morand-Joubert; Daniel Vittecoq; Françoise Roudot-Thoraval; Martine Mariotti; François Lefrère; Farhad Heshmati; Françoise Audat; P Lambin; F Barré-Sinoussi; Jean-Jacques Lefrère
Virological and immunological data of AIDS patients treated by passive immunotherapy (transfusions of plasma rich in HIV-1 antibodies).
Vox sanguinis 1997;73(3):149-54.
1997: Jean-Jacques Lefrère
[Descriptive epidemiology of hepatitis C virus infection in France in 1996].
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 1997;4(3):299-319.
1996: Jean-Jacques Lefrère; Françoise Roudot-Thoraval; D Vittecoq; Farhad Heshmati; Françoise Audat; Joëlle Lerable; D Reed; Jean-Claude Petit; Béatrice Burghoffer; Laurence Morand-Joubert
Quantitation of passively acquired human immunodeficiency virus (HIV) antibodies in AIDS patients transfused with a plasma that is rich in HIV antibodies.
Transfusion 1996;36(8):734-8.
1996: Jean-Jacques Lefrère; Marie-Caroline Meyohas; Martine Mariotti; Jean-Luc Meynard; M Thauvin; J Frottier
Detection of human herpesvirus 8 DNA sequences before the appearance of Kaposi's sarcoma in human immunodeficiency virus (HIV)-positive subjects with a known date of HIV seroconversion.
The Journal of infectious diseases 1996;174(2):283-7.
1996: Jean-Jacques Lefrère; Pascale Loiseau; Michèle Martinot-Peignoux; Martine Mariotti; N Ravera; M Thauvin; P Marcellin; C Janot
Infection by hepatitis C virus through contaminated intravenous immune globulin: results of a prospective national inquiry in France.
Transfusion 1996;36(5):394-7.
1995: Jean-Jacques Lefrère; Martine Mariotti
Use of digoxigenin-labelled probes for the detection of B19 parvovirus DNA in batches of blood products.
Cellular and molecular biology (Noisy-le-Grand, France) 1995;41(7):985-8.
1995: Laurence Morand-Joubert; H Bludau; Joëlle Lerable; Jean-Claude Petit; Jean-Jacques Lefrère
Serum anti-p24 antibody concentration has a predictive value on the decrease of CD4 lymphocyte count higher than acid-dissociated p24 antigen.
Journal of medical virology 1995;47(1):87-91.
1995: M C Meyohas; Laurence Morand-Joubert; P Van de Wiel; Martine Mariotti; Jean-Jacques Lefrère
Time to HIV seroconversion after needlestick injury.
Lancet 1995;345(8965):1634-5.
1995: Jean-Jacques Lefrère; Martine Mariotti; I De la Croix; Joëlle Lerable; M Thauvin; T Burnouf; G Folléa
Albumin batches and B19 parvovirus DNA.
Transfusion 1995;35(5):389-91.
1994: D G Costagliola; M de Montalembert; Jean-Jacques Lefrère; C Briand; Paolo Rebulla; Sylvain Baruchel; C Dessi; P Fondu; M Karagiorga; H Perrimond
Dose of desferrioxamine and evolution of HIV-1 infection in thalassaemic patients.
British journal of haematology 1994;87(4):849-52.
1994: Laurence Morand-Joubert; D Costagliola; H Bludau; Jean-Claude Petit; Jean-Jacques Lefrère
Predicting progression of HIV disease: usefulness of acid-dissociated p24 antigen.
Journal of acquired immune deficiency syndromes 1994;7(7):676-80.
1994: Jérôme Lamoril; F Lunel; P Laurent-Puig; Christine Defer; Pascale Loiseau; Jean-Jacques Lefrère; Jean-Michel Pawlotsky; P Marcellin; F Bouchardeau; Marc Bogard
Indeterminate third-generation recombinant immunoblot assay in hepatitis C virus infection. Group d'Etudes Moléculaires des Hépatites (GEMHEP).
Journal of hepatology 1994;21(1):133-4.
1994: S Chevret; M Kirstetter; Martine Mariotti; François Lefrère; J Frottier; Jean-Jacques Lefrère
Provirus copy number to predict disease progression in asymptomatic human immunodeficiency virus type 1 infection.
The Journal of infectious diseases 1994;169(4):882-5.
1994: V Massari; M H Elghouzzi; F Agis; C Rannou; E Gordien; D Costagliola; Jean-Jacques Lefrère
Epidemiologic comparison of human T-lymphotropic virus type I-infected blood donors from endemic and nonendemic regions over a 3-year period.
Transfusion 1994;34(3):198-201.
1994: Jean-Jacques Lefrère; Martine Mariotti; M Thauvin
B19 parvovirus DNA in solvent/detergent-treated anti-haemophilia concentrates.
Lancet 1994;343(8891):211-2.
1993: Martine Mariotti; E Wattel; François Lefrère; F Demange; Jean-Jacques Lefrère
Polymerase chain reaction procedure for rapid diagnosis of HIV infection.
AIDS (London, England) 1993;7(12):1680-1.
1993: Jean-Jacques Lefrère; M Debbia; P Lambin
Prospective follow-up of monoclonal gammopathies in HIV-infected individuals.
British journal of haematology 1993;84(1):151-5.
1993: M de Montalembert; E Wattel; François Lefrère; Martine Mariotti; F Agis; F Ferrer-le-Coeur; Robert Girot; Jean-Jacques Lefrère
Human T-cell lymphotropic virus type I and II DNA amplification in seropositive and seronegative at-risk individuals.
Transfusion 1993;33(2):106-10.
1992: S Chevret; H Roquin; P Ganne; Jean-Jacques Lefrère
Prognostic value of an elevated CD8 lymphocyte count in HIV infection. Results of a prospective study of 152 asymptomatic HIV-positive individuals.
AIDS (London, England) 1992;6(11):1349-52.
1992: Jean-Jacques Lefrère; Martine Mariotti; E Wattel; François Lefrère; G Inchauspe; D Costagliola; A Prince
Towards a new predictor of AIDS progression through the quantitation of HIV-1 DNA copies by PCR in HIV-infected individuals.
British journal of haematology 1992;82(2):467-71.
1992: François Lefrère; E Wattel; Martine Mariotti; F Agis; E Gordien; Jean-Jacques Lefrère
Absence of human T cell lymphotrophic virus (HTLV) type I and II DNA in French anti-HTLV-I/II-negative intravenous drug users.
The Journal of infectious diseases 1992;166(1):212-3.
1992: Christine Defer; H Agut; A Garbarg-Chenon; M Moncany; F Morinet; D Vignon; Martine Mariotti; Jean-Jacques Lefrère
Multicentre quality control of polymerase chain reaction for detection of HIV DNA.
AIDS (London, England) 1992;6(7):659-63.
1992: M de Montalembert; D G Costagliola; Jean-Jacques Lefrère; G Cornu; T Lombardo; S Cosentino; H Perrimond; Robert Girot
Prevalence of markers for human immunodeficiency virus types 1 and 2, human T-lymphotropic virus type I, cytomegalovirus, and hepatitis B and C virus in multiply transfused thalassemia patients. The French Study Group On Thalassaemia.
Transfusion 1992;32(6):509-12.
1992: D G Costagliola; Robert Girot; Paolo Rebulla; Jean-Jacques Lefrère
Incidence of AIDS in HIV-1 infected thalassaemia patients. European and Mediterranean W.H.O. Working Group on Haemoglobinopathies and Cooleycare.
British journal of haematology 1992;81(1):109-12.
1992: E Wattel; Martine Mariotti; F Agis; E Gordien; O Prou; A M Courouce; Philippe Rouger; S Wain-Hobson; I S Chen; Jean-Jacques Lefrère
Human T lymphotropic virus (HTLV) type I and II DNA amplification in HTLV-I/II-seropositive blood donors of the French West Indies.
The Journal of infectious diseases 1992;165(2):369-72.
1992: Jean-Jacques Lefrère; J Pillonel
Transmission groups of French HIV seropositive blood donors (August 1985-December 1990). The French Blood Centers.
Nouvelle revue française d'hématologie 1992;34(6):455-7.
1991: E Wattel; Martine Mariotti; J D Bignon; F Agis; E Gordien; J Y Muller; J Hors; Jean-Jacques Lefrère
No evidence of HTLV-I infection in French patients with multiple sclerosis using the polymerase chain reaction.
Journal of clinical pathology 1991;44(10):871-2.
1991: F Ferrer-Le-Coeur; Martine Mariotti; P Hivert; E P Satre; F Bouchardeau; Anne-Marie Couroucé; Philippe Rouger; Jean-Jacques Lefrère
No evidence of HIV-1 infection in seronegative hemophiliacs and in seronegative partners of seropositive hemophiliacs through polymerase chain reaction (PCR) and anti-NEF serology.
Thrombosis and haemostasis 1991;65(5):478-82.
1991: Jean-Jacques Lefrère; Martine Mariotti; D Vittecoq; B Noel; Anne-Marie Couroucé; P Lambin; C Salmon; Philippe Rouger
No evidence of frequent human immunodeficiency virus type 1 infection in seronegative at-risk individuals.
Transfusion 1991;31(3):205-11.
1991: Jean-Jacques Lefrère; M Mariotti; J Salpetrier; F Demange; E Wattel; Philippe Rouger; D Vittecoq
Polymerase chain reaction (PCR) in various stages of HIV infection. Relationship to disease progression.
Nouvelle revue française d'hématologie 1991;33(3):245-9.
1990: D Salmon; Anne-Marie Couroucé; C Doinel; J M Fine; Cécile Kaplan; P Lambin; Jean-Jacques Lefrère; Philippe Rouger; C Salmon
[ Biological criteria for prediction of the clinical course leading to AIDS].
Revue française de transfusion et d'hémobiologie : bulletin de la Société nationale de transfusion sanguine 1990;33(6):407-14.
1990: Jean-Jacques Lefrère; Martine Mariotti; F Ferrer-Le-Coeur; P Rouger; B Noël; C Bosser
PCR testing in HIV-1 seronegative haemophilia.
Lancet 1990;336(8727):1386.
1990: Jean-Jacques Lefrère; Anne-Marie Couroucé; Martine Mariotti; E Wattel; O Prou; F Bouchardeau; P Lambin
Rapid progression to AIDS in dual HIV-1/HTLV-I infection.
Lancet 1990;336(8713):509.
1990: Martine Mariotti; Jean-Jacques Lefrère; B Noel; F Ferrer-Le-Coeur; D Vittecoq; Robert Girot; C Bosser; Anne-Marie Couroucé; C Salmon; Philippe Rouger
DNA amplification of HIV-1 in seropositive individuals and in seronegative at-risk individuals.
AIDS (London, England) 1990;4(7):633-7.
1990: Jean-Jacques Lefrère; M de Montalembert; Martine Mariotti; R Girot; C Salmon; Philippe Rouger; J Rey
Absence of HIV DNA sequences in seronegative polytransfused thalassemic patients.
Vox sanguinis 1990;59(4):218-21.
1990: Cécile Kaplan; J Y Muller; C Doinel; Jean-Jacques Lefrère; F Paquez; Philippe Rouger; D Salmon; C Salmon
HLA-associated susceptibility to acquired immune deficiency syndrome in HIV-1-seropositive subjects.
Human heredity 1990;40(5):290-8.
1990: D Salmon; P Lambin; Anne-Marie Couroucé; Jean-Jacques Lefrère; C Doinel; Philippe Rouger; C Salmon
[Prediction of the clinical course of AIDS in a cohort of 77 seropositive persons. Importance of p24 antigen in the blood and the level of serum IgA].
Revue française de transfusion et d'hémobiologie : bulletin de la Société nationale de transfusion sanguine 1990;33(1):21-9.
1989: Jean-Jacques Lefrère; Martine Mariotti; Philippe Rouger; C Salmon
[The polymerase chain reaction and infection by human immunodeficiency virus (HIV)].
Revue française de transfusion et d'hémobiologie : bulletin de la Société nationale de transfusion sanguine 1989;32(6):431-49.
1989: Martine Mariotti; Jean-Jacques Lefrère; B Noël; F Ferrer-le-Coeur; D Vittecoq; Robert Girot; A M Courouce; C Salmon; Philippe Rouger
[DNA amplification using the polymerase chain reaction method applied to the detection of HIV-1 in seropositive subjects and in seronegative subjects at risk].
Revue française de transfusion et d'hémobiologie : bulletin de la Société nationale de transfusion sanguine 1989;32(4):253-63.
1989: Jean-Jacques Lefrère; R Girot; Joëlle Lerable; D Gozin; M Ducreux; K Chekara; J P Soulier
Study of the disappearance time of des-gamma-carboxyprothrombin under different conditions.
Thrombosis research 1989;55(5):645-9.
1988: Jean-Jacques Lefrère; J Conard; P Mavier; L Bettan; M Beaugrand; D Gozin; Joëlle Lerable; D Dhumeaux; M Samama
Coagulation assays as diagnostic markers of hepatocellular carcinoma.
Thrombosis and haemostasis 1988;60(3):468-70.
1988: L Mandelbrot; M Guillaumont; M Leclercq; Jean-Jacques Lefrère; D Gozin; F Daffos; F Forestier
Placental transfer of vitamin K1 and its implications in fetal hemostasis.
Thrombosis and haemostasis 1988;60(1):39-43.
1988: Jean-Jacques Lefrère; Anne-Marie Couroucé; G Lucotte; C Boitard; Cécile Kaplan; J C Nicolas; F Bricout; P Lambin; C Doinel; J Y Muller
Follow-up of subjects with isolated and persistent anti-core (anti-p24 or anti-p17) antibodies to HIV.
AIDS (London, England) 1988;2(4):287-90.
1988: Jean-Jacques Lefrère; M Leclercq; M Guillaumont; D Gozin; Joëlle Lerable
[Development of plasma levels of decarboxyprothrombin and vitamin K during treatment with moxalactam].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1988;9(2):223-5.
1988: J P Soulier; Jean-Jacques Lefrère; D Gozin
[Specificity of an elevated level of descarboxy-prothrombin in hepatocarcinoma after injection of vitamin K].
Annales de gastroentérologie et d'hépatologie 1988;24(2):77-9.
1988: J P Soulier; Jean-Jacques Lefrère; D Gozin
[Assay of decarboxy-prothrombin: its value in the diagnosis of hepatocellular carcinoma].
Annales de médecine interne 1988;139(1):7-11.
1987: Jean-Jacques Lefrère; D Eme; P Even; Philippe Rouger; F Ferrer-le-Coeur; B Noel; J Seger; C Salmon
HIV infection and Gc: absence of relationship.
AIDS (London, England) 1987;1(4):258-9.
1987: Jean-Jacques Lefrère; D Gozin; J P Soulier; L Bettan; P Mavier; D Dhumeaux; M Guillaumont; M Leclercq
Specificity of increased des-gamma-carboxyprothrombin in hepatocellular carcinoma after vitamin K1 injection.
Journal of hepatology 1987;5(1):27-9.
1987: Jean-Jacques Lefrère; D Gozin; L Bettan
Proaccelerin and prothrombin assays for detection of hepatocellular carcinoma.
Hepatology (Baltimore, Md.) 1987;7(2):414.
1986: Jean-Jacques Lefrère; M H Horellou; D Gozin; J Conard; J Y Muller; M Clark; J P Soulier; M Samama
A new case of high-molecular-weight kininogen inherited deficiency.
American journal of hematology 1986;22(4):415-9.
1986: Jean-Jacques Lefrère; J P Soulier; F Calvo; P Brice; D Gozin; F Guyon
[Application of a new method of assaying decarboxyprothrombin to the diagnosis of antivitamin K poisoning].
Presse médicale (Paris, France : 1983) 1986;15(5):214.
1986: J P Soulier; D Gozin; Jean-Jacques Lefrère
Assay of des-gamma-carboxyprothrombin using staphylocoagulase. Application to the diagnosis of cellular hepatocarcinoma.
Haematologia 1986;19(1):3-12.
1985: J P Soulier; D Gozin; Jean-Jacques Lefrère
[A new method of functional assay of des-gamma-carboxyprothrombin using staphylocoagulase. Application to the diagnosis of hepatocellular carcinoma].
Presse médicale (Paris, France : 1983) 1985;14(40):2049-52.